GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Medistim ASA (FRA:MD1) » Definitions » Cyclically Adjusted Price-to-FCF

Medistim ASA (FRA:MD1) Cyclically Adjusted Price-to-FCF : 35.32 (As of Jun. 04, 2025)


View and export this data going back to 2019. Start your Free Trial

What is Medistim ASA Cyclically Adjusted Price-to-FCF?

As of today (2025-06-04), Medistim ASA's current share price is €16.60. Medistim ASA's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2025 was €0.47. Medistim ASA's Cyclically Adjusted Price-to-FCF for today is 35.32.

The historical rank and industry rank for Medistim ASA's Cyclically Adjusted Price-to-FCF or its related term are showing as below:

FRA:MD1' s Cyclically Adjusted Price-to-FCF Range Over the Past 10 Years
Min: 25.93   Med: 55.72   Max: 126.33
Current: 36.39

During the past years, Medistim ASA's highest Cyclically Adjusted Price-to-FCF was 126.33. The lowest was 25.93. And the median was 55.72.

FRA:MD1's Cyclically Adjusted Price-to-FCF is ranked better than
50% of 248 companies
in the Medical Devices & Instruments industry
Industry Median: 36.435 vs FRA:MD1: 36.39

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

Medistim ASA's adjusted free cash flow per share data for the three months ended in Mar. 2025 was €0.089. Add all the adjusted free cash flow per share for the past 10 years together and divide 10 will get our Cyclically Adjusted FCF per Share, which is €0.47 for the trailing ten years ended in Mar. 2025.

Shiller PE for Stocks: The True Measure of Stock Valuation


Medistim ASA Cyclically Adjusted Price-to-FCF Historical Data

The historical data trend for Medistim ASA's Cyclically Adjusted Price-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medistim ASA Cyclically Adjusted Price-to-FCF Chart

Medistim ASA Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cyclically Adjusted Price-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only 88.94 105.10 55.77 44.59 28.10

Medistim ASA Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cyclically Adjusted Price-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 37.84 34.01 35.06 28.10 32.06

Competitive Comparison of Medistim ASA's Cyclically Adjusted Price-to-FCF

For the Medical Devices subindustry, Medistim ASA's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Medistim ASA's Cyclically Adjusted Price-to-FCF Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Medistim ASA's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Medistim ASA's Cyclically Adjusted Price-to-FCF falls into.


;
;

Medistim ASA Cyclically Adjusted Price-to-FCF Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted Price-to-FCF takes the Free Cash Flow per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/FCF calculation. Because it considers this 10-year average, it's often referred to as the CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF.

Medistim ASA's Cyclically Adjusted Price-to-FCF for today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/ Cyclically Adjusted FCF per Share
=16.60/0.47
=35.32

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Medistim ASA's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2025 is calculated as:

For example, Medistim ASA's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2025 was:

Adj_FreeCashFlowPerShare=Free Cash Flow per Share/CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=0.089/136.1000*136.1000
=0.089

Current CPI (Mar. 2025) = 136.1000.

Medistim ASA Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201506 0.048 100.100 0.065
201509 0.062 100.600 0.084
201512 0.119 100.900 0.161
201603 -0.003 102.500 -0.004
201606 0.039 103.800 0.051
201609 0.050 104.200 0.065
201612 0.098 104.400 0.128
201703 0.082 105.000 0.106
201706 -0.011 105.800 -0.014
201709 0.078 105.900 0.100
201712 0.205 106.100 0.263
201803 0.037 107.300 0.047
201806 0.028 108.500 0.035
201809 0.109 109.500 0.135
201812 0.142 109.800 0.176
201903 0.062 110.400 0.076
201906 0.106 110.600 0.130
201909 0.128 111.100 0.157
201912 0.152 111.300 0.186
202003 0.109 111.200 0.133
202006 0.092 112.100 0.112
202009 0.071 112.900 0.086
202012 0.102 112.900 0.123
202103 0.098 114.600 0.116
202106 0.116 115.300 0.137
202109 0.224 117.500 0.259
202112 0.249 118.900 0.285
202203 0.126 119.800 0.143
202206 0.147 122.600 0.163
202209 0.164 125.600 0.178
202212 0.171 125.900 0.185
202303 0.003 127.600 0.003
202306 0.147 130.400 0.153
202309 0.200 129.800 0.210
202312 0.214 131.900 0.221
202403 0.105 132.600 0.108
202406 0.121 133.800 0.123
202409 0.140 133.700 0.143
202412 0.304 134.800 0.307
202503 0.089 136.100 0.089

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Medistim ASA  (FRA:MD1) Cyclically Adjusted Price-to-FCF Explanation

Compared with the regular Price-to-Free-Cash-Flow, which works poorly for cyclical businesses, the Cyclically Adjusted Price-to-FCF smoothed out the fluctuations of free cash flow during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted Price-to-FCF should give similar results to regular Price-to-Free-Cash-Flow.


Medistim ASA Cyclically Adjusted Price-to-FCF Related Terms

Thank you for viewing the detailed overview of Medistim ASA's Cyclically Adjusted Price-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Medistim ASA Business Description

Traded in Other Exchanges
Address
Okernveien 94, Oslo, NOR, 0579
Medistim ASA is a medical device company. It is engaged in researching, developing, producing, distributing, and sales of medical equipment through its own business or participation in other companies, as well as related activities. The company's business is focused on cardiac and vascular surgery. The group operates in the USA, Europe, China, and the Rest of the World. The main divisions are sale of own products and sale of third-party products. Sale of own products has two business models, the capital model and the lease model. Third-party products segment sells medical devices from third party manufacturers in Norway, Sweden and Denmark. Key revenue is generated from Own Products segment.

Medistim ASA Headlines

No Headlines